Skip to main content
Registration
Registration Information
Visa Support Letters
Meeting Information
Academic Showcase
Award Winners
Hotel & Travel
FAQ
Accessibility
Sustainability
Conference Program
Full Schedule
Schedule-at-a-Glance
Preconference Skills Courses
Presenter/Poster Information
Browse By Date
Friday, August 23, 2024
Saturday, August 24, 2024
Sunday, August 25, 2024
Monday, August 26, 2024
Tuesday, August 27, 2024
Wednesday, August 28, 2024
Browse By Title
Browse By Speaker
Speaker Look-up
Posters
Spotlight Posters
Browse by Title
Browse by Author
Browse by Date
Tracks
Poster Gallery
Exhibitors & Sponsors
Become an Exhibitor/Sponsor
Exhibitor/Sponsor Login
Find an Exhibitor/Sponsor
Browse by Company
Floor Plan
Sponsor List
Evaluation
Conference App
Toggle navigation
Login
Search
Home
Registration
Registration Information
Visa Support Letters
Meeting Information
Academic Showcase
Award Winners
Hotel & Travel
FAQ
Accessibility
Sustainability
Conference Program
Full Schedule
Schedule-at-a-Glance
Preconference Skills Courses
Presenter/Poster Information
Browse By Date
Friday, August 23, 2024
Saturday, August 24, 2024
Sunday, August 25, 2024
Monday, August 26, 2024
Tuesday, August 27, 2024
Wednesday, August 28, 2024
Browse By Title
Browse By Speaker
Speaker Look-up
Posters
Spotlight Posters
Browse by Title
Browse by Author
Browse by Date
Tracks
Poster Gallery
Exhibitors & Sponsors
Become an Exhibitor/Sponsor
Exhibitor/Sponsor Login
Find an Exhibitor/Sponsor
Browse by Company
Floor Plan
Sponsor List
Evaluation
Conference App
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
15 results found
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
N
070
NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
Favorite
127
National trends in utilization of glucose lowering medications by older people with diabetes in long-term care facilities, 2009 to 2019
Favorite
BSPOT33
Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Favorite
335
Natural history of knee osteoarthritis with regards to other joint sites and knee replacement: a population-based cohort study in the UK Clinical Practice Research Datalink (CPRD)
Favorite
281
Neonatal Intensive Care Unit Services among Commercially Insured Infants in the United States, 2016 – 2023
Favorite
128
Network Analysis of Chronic Medication Use in Older Adults Living with Dementia Prior to and Following Diagnosis: A Web-based Visualisation Tool
Favorite
023
Neutropenia among patients with prostate cancer: Analysis of four US real world databases
Favorite
114
New Medication Use in Post-Acute Sequelae Of COVID-19 (PASC): An EHR-based Study From the RECOVER Program
Favorite
115
Nirmatrelvir and Ritonavir (Paxlovid) Prognostication: Unveiling Utilization Trends with Neural Network Time Series Forecasting
Favorite
116
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe Covid-19: An Analysis of the National Covid Cohort Collaborative (N3C)
Favorite
CSPOT50
No Elevated Risk of Cataract in Amiodarone Users: A Population-based Active-Comparator Study
Favorite
056
Non-Alcoholic Steatohepatitis (NASH) as a Risk Factor in Hepatocellular Carcinoma (HCC) Development
Favorite
346
Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Favorite
059
Novel Glucose-lowering Drugs and Incident Dementia Among Patients With Type 2 Diabetes and Comorbid Mental Disorders: A Population-based Cohort Study
Favorite
293
Nurses’ intention to report adverse drug events, a survey using the theory of planned behavior.
Favorite
Back to Top